[Evolution of serologically confirmed cases of mumps in the Madrid community, Spain, during a period of 7 years (2000--2006)].
OBJECTIVE
The aim of this study was to describe the evolution of serologically confirmed cases of mumps in the Madrid Community from 2000 to 2006.


METHODS
Cases with data about age, sex and with samples obtained < or = 30 days after the onset of symptoms were included. IgM determination was performed by indirect ELISA (Enzygnost Mumps; Dade Behring). IgM positive cases were considered as confirmed.


RESULTS
Information was available from 1,173 cases. Two hundred and fifty two of them (21.5%) were confirmed. The percentage of confirmed cases by year ranged between 21.4% and 27.2% (except for 2003 [10.7%], and 2004 [2.1%]). In the first years most confirmed cases corresponded to children (85.7% in 2000 and 68.6% in 2001) while in last years it was the opposite (10.7% in 2005 and 23.4% en 2006).


CONCLUSIONS
These results indicate the appearance of 2 epidemic waves (in 2000--2002 and in 2005--2006). Currently, mumps should not be considered an exclusively pediatric disease.
Sanz
Juan Carlos
JC
Laboratorio Regional de Salud Pública, Instituto de Salud Pública de la Comunidad de Madrid, Madrid, España. juan.sanz@salud.madrid.org
de Ory
Fernando
F
Fernández
Marisa
M
Herranz
Nieves
N
Méndez
Nazaret
N
Ramírez
Rosa
R
D000293:Adolescent; D000328:Adult; D000367:Age Factors; D000914:Antibodies, Viral / Q000097:blood; D002648:Child; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D006801:Humans; D007075:Immunoglobulin M / Q000097:blood; D008297:Male; D009107:Mumps / Q000453:epidemiology* / Q000276:immunology / Q000517:prevention & control; D009108:Mumps Vaccine / Q000008:administration & dosage; D009109:Mumps virus / Q000276:immunology; D012737:Sex Factors; D013030:Spain / Q000453:epidemiology
D000914:Antibodies, Viral; D007075:Immunoglobulin M; D009108:Mumps Vaccine